Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin versus duloxetine for knee osteoarthritis symptoms
IRCT20200516047468N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in knee osteoarthritis (OA) comparing Duloxetine with Melatonin (2 arms). Primary endpoint: Knee pain rate based on WOMAC index. Started Apr 2024; status: completed.
02
Drugs
melatoninduloxetine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20200516047468N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200516047468N2.